Long term safety, tolerability and efficacy of valsartan: Results from one and two year trials

Journal of Clinical Research

Volumn 1, Issue 147-159, 1998, Pages 147-159

  Hall, J ^a   Marbury, T ^a   Gray, J ^a   Chaudhery, S ^a   Chen, S ^a   James, D ^a   Hester, A ^a   Zheng, H ^a   Feliciano, N ^a   Lewis, G ^a  

^a Landmark Medical Center   (United States)

Author keywords

Angiotensin II antagonist; Essential hypertension; Extension trial; HCTZ; Valsartan

Indexed keywords

ANGIOTENSIN II ANTAGONIST; HYDROCHLOROTHIAZIDE; VALSARTAN;

ADULT; AGED; ARTHRALGIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COUGHING; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; ESSENTIAL HYPERTENSION; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPOKALEMIA; INFECTION; LEG PAIN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MULTICENTER STUDY; MUSCLE CRAMP; RANDOMIZED CONTROLLED TRIAL; THORAX PAIN; VERTIGO;

EID: 0031829733     PISSN: 13695207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)